Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas
Clinical trial NCT03715933 · RECRUITING
Trial details
- NCT number
- NCT03715933
- Sponsor
- Inhibrx Biosciences, Inc
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-08
- Primary completion
- 2028-12-01
- Enrollment
- 411
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.